The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients.

Vultaggio-Poma V, Sanz JM, Amico A, Violi A, Ghisellini S, Pizzicotti S, Passaro A, Papi A, Libanore M, Di Virgilio F, Giuliani AL

Open source

DOI
10.3389/fimmu.2023.1182454
Published
2023
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1182454,
  title = {The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients.},
  author = {Vultaggio-Poma V and Sanz JM and Amico A and Violi A and Ghisellini S and Pizzicotti S and Passaro A and Papi A and Libanore M and Di Virgilio F and Giuliani AL},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1182454},
  url = {https://doi.org/10.3389/fimmu.2023.1182454}
}

RIS

TY  - JOUR
TI  - The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients.
AU  - Vultaggio-Poma V
AU  - Sanz JM
AU  - Amico A
AU  - Violi A
AU  - Ghisellini S
AU  - Pizzicotti S
AU  - Passaro A
AU  - Papi A
AU  - Libanore M
AU  - Di Virgilio F
AU  - Giuliani AL
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1182454
UR  - https://doi.org/10.3389/fimmu.2023.1182454
ER  - 

APA

V, V., JM, S., A, A., A, V., S, G., S, P., A, P., A, P., M, L., F, D. V., & AL, G. (2023). The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1182454

Source records